Trial intelligence / Profile preview

Split-dose vs Standard-dose PMC for Bowel Cleansing in Children

NCT04767633Phase 3Unknown

Sponsor
Sant'Andrea Hospital
Start
Apr 2021
Primary completion
Apr 2022
Modality
Small Molecules
01

Overview

Phase 3, randomised, single-blind trial of sodium picosulfate + magnesium oxide + citric acid, sponsored by Sant'Andrea Hospital. Primary endpoint: Rate of successful bowel cleansing (BBPS score ≥ 6). Status: unknown.

02

Drugs

sodium picosulfate + magnesium oxide + citric acid

Beyond the preview

Go deeper on NCT04767633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04767633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call